| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038398876 |
| P356 | DOI | 10.2165/00003495-200059020-00001 |
| P698 | PubMed publication ID | 10730542 |
| P2093 | author name string | Mehta JL | |
| Romeo F | |||
| P2860 | cites work | Association between antibodies to heat shock protein 65 and coronary atherosclerosis. Possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk | Q74501639 |
| Pharmacodynamics of macrolides, azalides, and streptogramins: effect on extracellular pathogens | Q74802273 | ||
| Association of Helicobacter pylori infection with elevated serum lipids | Q77910810 | ||
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Nitric oxide: physiology, pathophysiology, and pharmacology | Q26778243 | ||
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies | Q33776566 | ||
| The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae | Q33843538 | ||
| Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability | Q33852673 | ||
| Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old) | Q34086738 | ||
| Compensatory enlargement of human atherosclerotic coronary arteries | Q34184275 | ||
| Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques | Q34327535 | ||
| Growth of Chlamydia psittaci in macrophages | Q34465881 | ||
| Herpes virus infection of endothelium: new insights into atherosclerosis | Q35234479 | ||
| Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease | Q35371043 | ||
| Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells | Q35488540 | ||
| Strong correlation between Helicobacter pylori seropositivity and Chlamydia pneumoniae IgG concentrations | Q35558055 | ||
| Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis | Q35764383 | ||
| High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis | Q35811381 | ||
| The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients | Q35816869 | ||
| Cytomegalovirus nucleic acid distribution within the human vascular tree | Q35831056 | ||
| Virus-induced atherosclerosis | Q36341613 | ||
| In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae | Q36524413 | ||
| Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms | Q36541516 | ||
| Cytokines and endothelial cell biology | Q36565690 | ||
| Lipoprotein(a), atherosclerosis and thrombosis | Q37135571 | ||
| Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis | Q37362297 | ||
| Viruses in the etiology of atherosclerosis | Q37618389 | ||
| Possible role of cytomegalovirus in atherogenesis | Q37875443 | ||
| Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study | Q37878753 | ||
| Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd | Q37878769 | ||
| Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis | Q37878782 | ||
| C-Reactive protein and coronary artery disease: additional evidence of the implication of an inflammatory process in acute coronary syndromes | Q37879244 | ||
| Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseases | Q37879945 | ||
| A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide | Q37879971 | ||
| Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery. | Q37880226 | ||
| Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression | Q37880399 | ||
| Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. | Q37880753 | ||
| Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease | Q37881093 | ||
| Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. | Q37881308 | ||
| Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
| Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research | Q37881887 | ||
| Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group | Q37882250 | ||
| Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction | Q37882420 | ||
| Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction | Q37882562 | ||
| Chlamydia species infect human vascular endothelial cells and induce procoagulant activity | Q37883093 | ||
| Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms | Q37883353 | ||
| Rabbit model for Chlamydia pneumoniae infection | Q37883934 | ||
| Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group | Q37883953 | ||
| Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease | Q37884972 | ||
| Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy | Q37885296 | ||
| Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. | Q37886690 | ||
| Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease | Q37887196 | ||
| Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques | Q37892518 | ||
| Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease | Q37892814 | ||
| Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study | Q37893723 | ||
| Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
| Molecular bases of the acute coronary syndromes | Q40530238 | ||
| Cytomegalovirus and atherosclerosis | Q40726892 | ||
| Change in blood pressure and 5-year risk of coronary heart disease among elderly men: the Finnish cohorts of the Seven Countries Study. | Q41017684 | ||
| Cytokines regulate vascular functions related to stability of the atherosclerotic plaque | Q41028054 | ||
| The iron hypothesis--does iron cause atherosclerosis? | Q41259409 | ||
| Homocysteine and thrombotic disease. | Q41518187 | ||
| The oncogenic potential of herpes simplex viruses: evidence for a ‘hit-and-run’ mechanism | Q41555454 | ||
| Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. | Q41576959 | ||
| Homocysteinemia as a risk factor for atherosclerosis: a review | Q41678293 | ||
| Regulation of major histocompatibility gene expression in human vascular smooth muscle cells | Q42490161 | ||
| Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. | Q42756215 | ||
| Alternative hypothesis for efficacy of macrolides in acute coronary syndromes | Q43429541 | ||
| Viral and bacterial infections in patients with acute myocardial infarction | Q45004940 | ||
| Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis | Q45108781 | ||
| Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study | Q45221518 | ||
| The effect of virus infection on the adherence of leukocytes or platelets to endothelial cells | Q45862853 | ||
| Helicobacter pylori seropositivity and coronary heart disease incidence. Atherosclerosis Risk In Communities (ARIC) Study Investigators. | Q50866437 | ||
| Association of virulent Helicobacter pylori strains with ischemic heart disease. | Q50887983 | ||
| Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. | Q51012002 | ||
| Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators. | Q52306854 | ||
| Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. | Q52432373 | ||
| The modernization of Asia. Implications for coronary heart disease. Council on Arteriosclerosis of the International Society and Federation of Cardiology. | Q53364316 | ||
| White blood cell count and haematocrit as predictors of coronary recurrence after myocardial infarction. | Q54485651 | ||
| The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina | Q58230388 | ||
| Transient intermittent lymphocyte activation is responsible for the instability of angina | Q58464956 | ||
| High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis | Q63983805 | ||
| Cytomegalovirus-induced regulation of major histocompatibility complex class I antigen expression in human aortic smooth muscle cells | Q68262795 | ||
| Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart | Q68493863 | ||
| Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction | Q68797489 | ||
| Neutrophil function in ischemic heart disease | Q69329605 | ||
| Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response | Q69742103 | ||
| The leukocyte count as a predictor of myocardial infarction | Q69762702 | ||
| Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy | Q71210092 | ||
| Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease | Q71244128 | ||
| Does atherosclerosis have an infectious etiology? | Q71493511 | ||
| Cytomegalovirus modulates interleukin-6 gene expression | Q71588952 | ||
| Inflammation and coronary artery disease | Q72071558 | ||
| Effect of risk factors and changes in risk factors on coronary mortality in three cohorts of middle-aged people in eastern Finland | Q72361255 | ||
| A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association | Q72415283 | ||
| Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology | Q72708405 | ||
| Importance of Lp(a) lipoprotein and HLA genotypes in atherosclerosis and diabetes | Q72875873 | ||
| The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment | Q73071011 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 159-170 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Inflammation, infection and atherosclerosis: do antibacterials have a role in the therapy of coronary artery disease? | |
| P478 | volume | 59 |
Search more.